TransAct Q3 Sales Up 10% but Swings to Loss; Cuts Full-Year EBITDA Outlook
TACT sits 59% above its 52-week low of $3.06 on light trading volume (0.2× avg).
Summary
TransAct posted preliminary Q3 net sales of $14.4 million, up 10% year-over-year, driven by food service technology revenue up 33% to $6.4 million and software revenue up roughly 61% to $876 thousand. Casino and Gaming sales fell 11% to $6.4 million, and management expects the softer demand to continue into Q4. The mix shift and higher selling costs pushed the company to an operating loss of $415 thousand and a net loss of $440 thousand, or $0.04 per diluted share, versus a small profit a year ago; adjusted EBITDA dropped to $289 thousand from $669 thousand. Full-year 2026 guidance now calls for net sales of $55-56 million and adjusted EBITDA of $1.5-1.75 million. Separately, the Board said it is evaluating a broader range of strategic alternatives beyond the Casino and Gaming review, including a potential sale of the FST business, with BofA advising and no public timetable set. This lands four days after activist Charles Gillman's fourth 13D/A demanding an independent investment bank and strategic action, so the widened review is the key item to track.
At the time of this announcement, TACT was trading at $4.88 on NASDAQ in the Technology sector, with a market capitalization of approximately $50.4M. The 52-week trading range was $3.06 to $6.02. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.